Transcription Regulation In Vertebrate Eye Development
脊椎动物眼睛发育中的转录调控
基本信息
- 批准号:8342204
- 负责人:
- 金额:$ 84.08万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AddressAdultBiochemicalBiologicalBlindnessBone Morphogenetic ProteinsCell CycleCell LineageCell ProliferationCell TherapyCellsDevelopmentDevelopmental BiologyDiseaseDorsalEpitheliumEventEyeEye DevelopmentFibroblast Growth FactorFutureGenerationsGeneticGoalsHelix-Turn-Helix MotifsHomeodomain ProteinsHumanIn VitroIndividualIrisKnowledgeMacular degenerationMethodsMolecularMonitorOpticsOrganPathogenesisPlayProcessRegulationRetinaRetinalRoleSignal TransductionSignaling MoleculeStructure of retinal pigment epitheliumTimeTranscriptional RegulationTransforming Growth Factor betablastomere structurecell typein vivoinduced pluripotent stem cellinsightmicrophthalmia-associated transcription factormonolayerneuroepitheliumoptic cupoptic stalkparalogous generesearch studyresponsetranscription factor
项目摘要
A critical event in vertebrate eye development is the early separation of the seemingly uniform epithelium of the optic cup into a domain that will become the multilayered retina and a domain that will become the monolayer retinal pigment epithelium or RPE. This separation is controlled by a number of signaling molecules and transcription factors including fibroblast growth factors (FGFs), bone morphogenetic proteins, transforming growth factor-betas, the homeodomain proteins PAX6 and VAX1/2, and the basic helix-loop-helix-zipper protein MITF. One of the early signs of the action of these factors is the establishment of a differential rate of cell proliferation which is high in the future retina and low in the future RPE. This fact prompted us to initiate studies in which we correlate cell cycle parameters with cell signaling and transcription regulation. Interestingly, it appears that peak activities in cell signaling responses may be cell cycle-specific. In separate experiments, we have identified a regulatory loop that involves PAX6, MITF, its paralog TCFEC, and WNT-regulating signaling factors and that is crucial for RPE and retina development. The studies show that PAX6, well-known for its pro-retinogenic activity in the retina, has in fact anti-retinogenic roles in the future RPE, particularly in its dorsal part. Similar roles are played by VAX1/2 in the ventral RPE. A detailed knowledge on the mechanisms regulating early development in vivo may become important for the generation of retinal and RPE cells from embryonic or induced pluripotent stem cells in vitro. Such cells hold much promise for cell-based therapies in human blindness, including adult onset macular degeneration, and for studying the pathogenesis of such diseases at the molecular level. Nevertheless, at the present time, the process of their generation is still not very well controlled and it remains to be seen whether they represent truly authentic cell types. A careful monitoring of the activities of PAX6 and its regulatory partners may therefore become important to efficiently generate functional RPE and retinal cells in vitro.
脊椎动物眼发育中的一个关键事件是,光学杯的看似均匀上皮的早期分离为一个域,该域将成为多层视网膜和一个将成为单层视网膜色素上皮或RPE的域。这种分离受许多信号分子和转录因子的控制,包括成纤维细胞生长因子(FGF),骨形态发生蛋白,转化生长因子 - 贝塔斯,同源构域蛋白PAX6和VAX1/2,以及基本的Helix-loop-helix-Zipper-Zipper-Zipper-Zipper蛋白MITF。这些因素作用的早期迹象之一是建立了细胞增殖的差异速率,这在未来的视网膜中很高,而将来的RPE差异很低。这一事实促使我们启动研究,其中我们将细胞周期参数与细胞信号传导和转录调控相关。有趣的是,看来细胞信号反应中的峰活动可能是细胞周期特异性的。在单独的实验中,我们确定了涉及PAX6,MITF,其旁系同源物TCFEC和WNT调节信号传导因子的调节循环,这对于RPE和RPE和视网膜开发至关重要。研究表明,PAX6以其在视网膜中的促归报活性而闻名,实际上在未来的RPE中具有抗归还作用,尤其是在其背部。 VAX1/2在腹侧RPE中扮演类似的角色。关于调节体内早期发育机制的详细知识对于从胚胎或诱导的多能干细胞的体外产生视网膜和RPE细胞可能变得很重要。这些细胞对人类失明的基于细胞的疗法具有很大的希望,包括成年发作性黄斑变性,并研究了分子水平上此类疾病的发病机理。然而,目前,他们这一代的过程仍然不是很好的控制,还有待观察它们是否代表真正的真实细胞类型。因此,仔细监测PAX6及其调节伙伴的活动可能对在体外有效产生功能性RPE和视网膜细胞可能很重要。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HEINZ ARNHEITER其他文献
HEINZ ARNHEITER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HEINZ ARNHEITER', 18)}}的其他基金
Signaling And Transcription Regulation In Nervous System
神经系统中的信号传导和转录调节
- 批准号:
6842481 - 财政年份:
- 资助金额:
$ 84.08万 - 项目类别:
Transcription Regulation In Vertebrate Eye Development
脊椎动物眼睛发育中的转录调控
- 批准号:
8557007 - 财政年份:
- 资助金额:
$ 84.08万 - 项目类别:
The Role of Transcription Factor Isoforms in Eye and Neural Crest Development
转录因子亚型在眼睛和神经嵴发育中的作用
- 批准号:
7969631 - 财政年份:
- 资助金额:
$ 84.08万 - 项目类别:
Transcription Regulation In Vertebrate Eye Development
脊椎动物眼睛发育中的转录调控
- 批准号:
8158173 - 财政年份:
- 资助金额:
$ 84.08万 - 项目类别:
Signaling And Transcription Regulation In Nervous System
神经系统中的信号传导和转录调节
- 批准号:
6501277 - 财政年份:
- 资助金额:
$ 84.08万 - 项目类别:
SIGNALING AND TRANSCRIPTION REGULATION IN NERVOUS SYSTEM DEVELOPMENT
神经系统发育中的信号传导和转录调节
- 批准号:
6432904 - 财政年份:
- 资助金额:
$ 84.08万 - 项目类别:
Transcription Regulation In Vertebrate Eye Development
脊椎动物眼睛发育中的转录调控
- 批准号:
7969537 - 财政年份:
- 资助金额:
$ 84.08万 - 项目类别:
Transcription Regulation In Vertebrate Eye Development
脊椎动物眼睛发育中的转录调控
- 批准号:
7594659 - 财政年份:
- 资助金额:
$ 84.08万 - 项目类别:
The Role of Transcription Factor Isoforms in Eye and Neural Crest Development
转录因子亚型在眼睛和神经嵴发育中的作用
- 批准号:
7594712 - 财政年份:
- 资助金额:
$ 84.08万 - 项目类别:
Transcription Regulation In Vertebrate Eye Development
脊椎动物眼睛发育中的转录调控
- 批准号:
7735262 - 财政年份:
- 资助金额:
$ 84.08万 - 项目类别:
相似国自然基金
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
- 批准号:82302025
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
- 批准号:82302311
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Endothelial Cell Reprogramming in Familial Intracranial Aneurysm
家族性颅内动脉瘤的内皮细胞重编程
- 批准号:
10595404 - 财政年份:2023
- 资助金额:
$ 84.08万 - 项目类别:
Role of skeletal muscle IPMK in nutrient metabolism and exercise
骨骼肌IPMK在营养代谢和运动中的作用
- 批准号:
10639073 - 财政年份:2023
- 资助金额:
$ 84.08万 - 项目类别:
REVAMP-PH: REpurposing Valsartan May Protect against Pulmonary Hypertension
REVAMP-PH:重新利用缬沙坦可以预防肺动脉高压
- 批准号:
10642368 - 财政年份:2023
- 资助金额:
$ 84.08万 - 项目类别:
Project 2: Informing oral nicotine pouch regulations to promote public health
项目 2:告知口服尼古丁袋法规以促进公共卫生
- 批准号:
10666068 - 财政年份:2023
- 资助金额:
$ 84.08万 - 项目类别:
Assessing the real-world impact of a low nicotine product standard for smoked tobacco in New Zealand
评估新西兰低尼古丁产品标准对吸食烟草的现实影响
- 批准号:
10665851 - 财政年份:2023
- 资助金额:
$ 84.08万 - 项目类别: